1 results match your criteria: "Royal Surrey County and St Luke's Hospitals Trust[Affiliation]"
Octreotide exacerbated fasting hypoglycaemia in a patient with a proinsulinoma; the glucostatic importance of pancreatic glucagon.
Clin Endocrinol (Oxf)
July 1995
Department of Clinical Biochemistry, Royal Surrey County and St Luke's Hospitals Trust, Guildford, Surrey, UK.
Octreotide, a long-acting somatostatin analogue, has been used to alleviate hypoglycaemia in patients with insulinomas. Transient worsening of fasting hypoglycaemia following octreotide has also been described (Stehouwer et al., 1989).
View Article and Find Full Text PDF